Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03647878 |
|---|---|
| Brief Title: | Study of Cabozantinib as Monotherapy or in Combination With Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma Under Real-life Clinical Setting in 1st Line Treatment. (CABOCARE) |
| First Submitted : | July 25, 2018 |
| First Submitted that Met QC Criteria : | August 24, 2018 |
| First Posted : | August 27, 2018 |
| Last Update Submitted that Met QC Criteria : | March 6, 2023 |
| Last Update Posted : | March 7, 2023 |